Back to search

Article

Antibody Responses After Oxford Astrazeneca (Covishield) Vaccine Among Healthcare Workers in Dhaka Medical College, Dhaka, Bangladesh

2021-10-14

Abstract excerpt

Background: Oxford AstraZeneca (Covishield) vaccine is the 1<sup>st</sup> vaccine administered in Bangladesh to prevent the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed the antibody response after 1<sup>st</sup> and 2<sup>nd</sup> dose of this vaccine in health care workers of Dhaka Medical College hospital, Bangladesh.<br><br>Methods: Health care workers (teachers, clinician...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
76dae05f-f461-51e2-8dc4-60f1fe781726
DOI
10.2139/ssrn.3942643
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antibody Responses After Oxford Astrazeneca (Covishield) Vaccine Among Healthcare Workers in Dhaka Medical College, Dhaka, BangladeshDOI 10.2139/ssrn.3942643
Neutralizing SARS-CoV-2 Antibody Response to 1st Dose of Astrazeneca-Oxford AZD1222 Vaccine Among Health Workers in North-Central NigeriaSemantic proximity
Interim results from comparison of immune responses elicited by an inactivated and a vectored SARS-CoV-2 vaccine in seronegative and seropositive participants in IndiaSemantic proximity
Immunogenic superiority and safety of Biological E CORBEVAX vaccine compared to COVISHIELD (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trialSemantic proximity
Sero-surveillance of SARS-CoV-2 specific antibody (IgG) among garment workers in BangladeshSemantic proximity
Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individualsSemantic proximity
Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1Semantic proximity
Humoral and cellular response three months following bivalent booster administrationSemantic proximity
Early T Cell and Binding Antibody Responses are Associated with COVID-19 RNA Vaccine Efficacy OnsetSemantic proximity
Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b studySemantic proximity
Short-Term Immune Response After Inactivated SARS-CoV-2 (CoronaVac®, Sinovac) And ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) Vaccinations in Thai Health Care WorkersSemantic proximity
Trends in Antibody Titers after SARS-CoV-2 Vaccination - Insights from a Self-Paid Tests at a General Internal Medicine ClinicSemantic proximity
Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in BangladeshSemantic proximity
Select a neighboring publication to make it the new centre.